Protease Inhibition by Bismuth Subcitrate (DE-NOL): A Possible Therapeutic Mechanism?

Bird, N.M.; Green, H.T.; Rhodes, Jonathan M.

doi:10.1042/cs073033Pa

Skip Nav Destination

Article navigation

Conference Abstract| December 01 1987

Protease Inhibition by Bismuth Subcitrate (DE-NOL): A Possible Therapeutic Mechanism?

N.M. Bird;

N.M. Bird

1University Dept. of Medicine and Dept. of Microbiology Walton Hospital, Liverpool

Search for other works by this author on:

This Site

PubMed

Google Scholar

H.T. Green;

H.T. Green

1University Dept. of Medicine and Dept. of Microbiology Walton Hospital, Liverpool

Search for other works by this author on:

This Site

PubMed

Google Scholar

Jonathan M. Rhodes

1University Dept. of Medicine and Dept. of Microbiology Walton Hospital, Liverpool

Search for other works by this author on:

This Site

PubMed

Google Scholar

Clin Sci (Lond) (1987) 73 (s17): 33P.

https://doi.org/10.1042/cs073033Pa

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Portland Press

Registered address – First Floor, 10 Queen Street Place, London EC4R 1BE
Mailing address – 1 Naoroji Street, London WC1X 0GB

Portland Press Tel
+44 (0)20 3880 2795

Biochemical Society Tel
+44 (0)20 3880 2793
Email: editorial@portlandpress.com

Company no. 00892796
Registered Charity no. 253894
VAT no. GB 523 2392 69

Privacy and cookies
Accessibility

Protease Inhibition by Bismuth Subcitrate (DE-NOL): A Possible Therapeutic Mechanism?

Article PDF first page preview

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

Cover Image

Protease Inhibition by Bismuth Subcitrate (DE-NOL): A Possible Therapeutic Mechanism?

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only